Xoom
  • Home (current)
  • Covid-19 Advisory
  • About Us
    • Vision, Mission & Core Values
    • Medical Board
    • The Team
    • Our Authorised Partner Pharmacies
    • Our Awards
  • Our Services
    • For Pharmacy
    • For Corporates
    • Vaccination
    • COVID-19 HOME CARE PLAN
    • Diabetes Management
    • Virtual HIV/STD Clinic
  • MEDIA CENTRE
    • PRESS RELEASE
    • MEDIA KIT
    • NEWSROOM
  • Health Tips
  • ePharmacyNew!
    • Malaysia

Newsroom

  • Home
  • Newsroom
  • [Lowyat.NET]DOC2US Launches AI System To Manage COVID-19 Rapid Test Results

DOC2US has launched it’s proprietary Rapid Test Kit Intelligent System (RTKis) which will test, record, manage, and report COVID-19 cases for corporates and the public. For those unfamiliar, DOC2US is a Ministry of Health-approved telemedicine provider that distributes digitally signed e-prescription services in Malaysia.

According to the online healthcare provider, RTKis (pronounced as Ar-Tee-kis) provides a cost-effective, credible, and convenient means to comply with guidelines set by the Ministry of International Trade & Industry (MITI) for economic sectors allowed to operate under Phase 2 of the National Recovery Plan. The system takes advantage of the self-test kits recently approved by the Medical Device Authority (MDA) which allows individuals to take Antigen Rapid tests in the comfort of their homes. Basically, after users conduct the self-test, they can then submit the result on RTKis which uses artificial intelligence to validate the test result. Positive results will be uploaded to the Public Health Laboratory Information System (SIMKA) which is synchronized with MySejahtera.

DOC2US says that the use of AI, in addition to the unique QR codes that come with each RTK antigen test kit sold under their package, will minimise the risks of fraud from self-declaration. Their anti-fraud measures also include phone number verification, identity verification through identity card, and requiring users to take photos and videos of the test process.

“Our AI-powered system is using image classification engine with machine learning to identify the test result based on the uploaded test kit photo,” said DOC2US Chief Technology Officer Tan Aik Keong, who developed the backend system.

Currently, RTKis only works with Gmate, a saliva-based COVID-19 self-test kit imported from South Korea. That being said, Dr Raymond Choy, Chief Executive Officer of DOC2US, adds that their system is designed to work with other test kits as well. Another test kit, locally-manufactured Salixium, also claims to have a companion app that integrates with MySejahtera, although it has yet to be launched. DOC2US’ RTKis package is sold at RM45 each.

(Source: DOC2US [Official website])

 

Original Source: https://www.lowyat.net/2021/246722/doc2us-launches-ai-system-to-manage-covid-19-rapid-test-results/

Tags :

  • Rapid Test Kit Intelligent System (RTKis) |
  • COVID-19 |
  • COVID-19 self-test kits

Share :

Written by

DOC2US

Latest News

Celebrating 2 Million Electronic Prescriptions Milestone at DOC2US!

Celebrating 2 Million Electron...

Dec 12, 2023

DOC2US, University of Malaya & Taylor’s University Achieve Milestone Publication in Sage Journals

DOC2US, University of Malaya &...

Nov 24, 2023

Haier Teams Up with DOC2US and AIA to Prioritise Employee Health

Haier Teams Up with DOC2US and...

Nov 23, 2023

DOC2US Backs Gentari's Employee Wellbeing Initiative

DOC2US Backs Gentari's Employe...

Nov 15, 2023

Citibank Collaborates With DOC2US for On-Site Flu Vaccination & Health Screening

Citibank Collaborates With DOC...

Nov 06, 2023

Standard Chartered Initiates Second Round of Flu Vaccinations and Basic Health Screenings in Response to High Demand

Standard Chartered Initiates S...

Oct 27, 2023

Introducing DOC2US, Your Trusted Online Doctor. With its name synonymous to “talk to us”, DOC2US is a mobile application that allows you to talk to a doctor or any healthcare professionals via text chat at any time and from anywhere.

USEFUL LINKS

  • Home
  • About Us
  • For Pharmacy
  • Health Tips
  • Feedback
  • Fun Facts
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms
  • Telemedicine Policy
  • Medicine e-Prescription SOP

SITEMAP

Copyright © 2025 HEYDOC INTERNATIONAL SDN. BHD. (1141230-T) - ALL RIGHTS RESERVED  |   Powered by etc web design